Pfeifer Andrea's Form 4/A amendment
AmendedAC Immune SA (ACIU) · filed Apr 16, 2026
- Accession no.
- 0001651625-26-000006
- Filed
- Apr 16, 2026
- Trade date
- Apr 15, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
- Original filed
- Apr 16, 2026
This filing lists 1 non-derivative transaction. Open-market sales total $31.4K. It was filed 1 day after the trade.
This amendment replaces 0001651625-26-000005 (filed Apr 16, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pfeifer AndreaCIK 0001697107 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | Share | SSaleDisposed | −10,000 | $3.14F2 | −$31,400 | 3,830,288 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This Form 4/A amends the Form 4 filed on April 16, 2026, inadvertently reporting in column 3 a purchase of 10,000 shares on behalf of the reporting person. This amendment corrects that filing to reflect that the reporting person sold 10,000 shares.
- F2
The price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.05 to $3.19, inclusive.
Referenced by the price of 1 transaction in Table I.
- F3
Includes 1,921,005 common shares underlying outstanding restricted share units.